+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 70Years
All Genders
ID06095154

Phase III Study Comparing Modified Radiation Targeting Using Geometric Expansion From Tumor in Nasopharyngeal Cancer Patients

Led by Fujian Cancer Hospital · Updated on 2025-03-13

474

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new method of defining clinical target volumes CTV using geometric expansion from the gross tumor volume GTV in patients who have newly diagnosed nasopharyngeal carcinoma without distant metastasis. This phase III randomized, multi-center trial aims to assess the effectiveness and safety of this modified intensity-modulated radiation therapy IMRT approach compared to standard CTV delineation methods. All participants will receive IMRT treatment using techniques such as IMRT, VMAT, or TOMOTHERAPY, based on available equipment and patient preference. They will be randomly assigned in equal groups to either the experimental group, where CTV delineation is based solely on geometric expansion from GTV, or the control group, which uses traditional target definitions including additional margins and high-risk areas. Prescribed doses vary for different target regions, with specific dose levels assigned to gross tumor volumes and clinical target volumes over 33 fractions. Participants will undergo regular follow-up visits including imaging and clinical assessments to monitor local failure-free survival, overall survival, regional failure-free survival, distant metastasis-free survival, and quality of life over three years. The study includes ongoing monitoring of treatment effects and safety, with follow-up continuing for up to three years after treatment completion. The total participation duration varies depending on individual treatment and follow-up schedules.

CONDITIONS

Brief Title

CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma

Research Team

S

Shaojun Lin, DR

Q

Qiaojuan Guo, DR

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here